CHICAGO, Oct. 1 /PRNewswire/ -- Abiant, Inc., an Illinois based company specializing advanced bio-imaging to accelerate and improve drug development and disease diagnosis, announces the successful closing of a $600,000 private placement. Lead investor Heartland Angels, an angel network specializing in early-stage technology, syndicated the round with Kettering Medical Center and other participants. Abiant has developed partnerships with large pharmaceutical companies and with academic collaborators. The company has obtained an exclusive license from New York University School of Medicine to image processing technology that has enabled the early and accurate identification of dementias.
